ALNYLAM PHARMACEUTICALS, INC. Accrued Income Taxes, Current
ALNYLAM PHARMACEUTICALS, INC. (ALNY) had Accrued Income Taxes, Current of $0 as of 2010-12-31, per its 10-K filed 2011-02-18.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2011-02-18
- 2010-12-31: Accrued Income Taxes, Current $0.00.
- 2010-09-30: Accrued Income Taxes, Current $237.00K.
- 2010-06-30: Accrued Income Taxes, Current $272.00K.
- 2009-12-31: Accrued Income Taxes, Current $5.52M; Accrued Income Taxes, Current as first filed $5.64M.
| Period end | Accrued Income Taxes, Current | Accrued Income Taxes, Current as first filed |
|---|---|---|
| 2010-12-31 | $0.00 10-K · filed 2011-02-18 | |
| 2010-09-30 | $237.00K 10-Q · filed 2010-11-04 | |
| 2010-06-30 | $272.00K 10-Q · filed 2010-08-05 | |
| 2009-12-31 | $5.52M 10-K · filed 2011-02-18 | $5.64M 10-Q · filed 2010-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |